Difference in oral effectiveness of two tyrosine hydroxylase inhibitors.
D000818:Animals; D001835:Body Weight; D001921:Brain / Q000187:drug effects; D001923:Brain Chemistry; D003913:Dextroamphetamine / Q000494:pharmacology*; D004032:Diet; D004298:Dopamine / Q000032:analysis; D004435:Eating; D004798:Enzymes / Q000494:pharmacology*; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D009068:Movement / Q000187:drug effects; D009638:Norepinephrine / Q000032:analysis; D010088:Oxidoreductases; D012110:Reserpine / Q000494:pharmacology*; D012701:Serotonin / Q000032:analysis; D014443:Tyrosine / Q000494:pharmacology*
D004798:Enzymes; D008781:Methyltyrosines; D012701:Serotonin; D014443:Tyrosine; D012110:Reserpine; D010088:Oxidoreductases; D003913:Dextroamphetamine; D004298:Dopamine; D009638:Norepinephrine